Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form

Blood Cells Molecules and Diseases

Journal
uri icon
  • Overview
  • Identity
  • View All
scroll to property group menus

Overview

articles

  • Heterozygous congenital Factor VII deficiency with the 9729de14 mutation, associated with severe spontaneous intracranial bleeding in an adolescent male.  57:8-12. 2016
  • Neurotoxicity of the anticoagulant-selective E149A-activated protein C variant after focal ischemic stroke in mice.  51:104-108. 2013
  • Severe microcytic anemia but increased erythropoiesis in mice lacking hfe or tfr2 and tmprss6.  48:173-178. 2012
  • Common tmprss6 mutations and iron, erythrocyte, and pica phenotypes in 48 women with iron deficiency or depletion.  48:124-127. 2012
  • The familial parkinson's disease gene dj-1 (park7) is expressed in red cells and plays a role in protection against oxidative damage.  45:227-232. 2010
  • Polymorphisms and mutations of human tmprss6 in iron deficiency anemia.  44:16-21. 2010
  • Severe iron overload with a novel aminolevulinate synthase mutation and hepatitis c infection. A case report.  42:1-4. 2009
  • The anemia of ageing is not associated with increased plasma hepcidin levels.  41:252-254. 2008
  • Human chitotriosidase polymorphisms g354r and a442v associated with reduced enzyme activity.  39:353-360. 2007
  • The role of stat, ap-1, e-box and tieg motifs in the regulation of hepcidin by il-6 and bmp-9: Lessons from human hamp and murine hamp1 and hamp2 gene promoters.  39:255-262. 2007
  • Slc40a1 q248h allele frequencies and q248h-associated risk of non-hfe iron overload in persons of sub-saharan african descent.  39:206-211. 2007
  • In vivo imaging of hepcidin promoter stimulation by iron and inflammation.  38:253-257. 2007
  • Disparate phenotypic expression of alas2 r452h (nt 1407 g -> a) in two brothers, one with severe sideroblastic anemia and iron overload, hepatic cirrhosis, and hepatocellular carcinoma.  36:342-346. 2006
  • Platelet interactions with vessel wall components during thrombogenesis.  36:145-147. 2006
  • The promise of protein C.  36:211-216. 2006
  • Three kinships with alas2 p520l (c. 1559 c -> t) mutation, two in association with severe iron overload, and one with sideroblastic anemia and severe iron overload.  36:292-297. 2006
  • Iron overload in an african american woman with ss hemoglobinopathy and a promoter mutation in the x-linked erythroid-specific 5-aminolevulinate synthase (alas2) gene.  34:226-228. 2005
  • Autosomal dominant hereditary hemochromatosis associated with a novel ferroportin mutation and unique clinical features.  34:157-161. 2005
  • Chronic inflammation does not appear to modify the homozygous hereditary hemochromatosis phenotype.  35:326-327. 2005
  • The mitochondrial nt 16189 polymorphism and hereditary hemochromatosis.  33:344-345. 2004
  • A single amino acid change in the binding pocket alters specificity of an anti-integrin antibody AP7.4 as revealed by its crystal structure.  32:176-181. 2004
  • Ferroportin 1 (SCL40A1) variant associated with iron overload in African-Americans.  31:305-309. 2003
  • Recombinant murine-activated protein C is neuroprotective in a murine ischemic stroke model.  30:271-276. 2003
  • Penetrance of hemochromatosis.  29:418-432. 2002
  • Seeking candidate mutations that affect iron homeostasis.  29:471-487. 2002
  • Activated protein C-dependent and -independent anticoagulant activities of protein S have different structural requirements.  29:190-199. 2002
  • Low protein Z levels and risk of ischemic stroke: differences by diabetic status and gender.  29:139-144. 2002
  • Protein C pathway impairment in nonsymptomatic cigarette smokers.  29:73-82. 2002
  • A study of genes that may modulate the expression of hereditary hemochromatosis: Transferrin receptor-1, ferroportin, ceruloplasmin, ferritin light and heavy chains, iron regulatory proteins (irp)-1 and-2, and hepcidin.  27:783-802. 2001
  • Polymorphisms in the transferrin 5 ' flanking region associated with differences in total iron binding capacity: Possible implications in iron homeostasis.  27:539-548. 2001
  • Mutation analysis of the transferrin receptor-2 gene in patients with iron overload.  27:285-289. 2001
  • The hfe gene of browsing and grazing rhinoceroses: A possible site of adaptation to a low-iron diet.  27:342-350. 2001
  • Tissue- and epitope-specific mechanisms account for the diverse effects of anti-CD44 antibodies on the maintenance of primitive hematopoietic progenitors in vitro.  26:291-302. 2000
  • Gamma heavy chain disease in man: Independent structural abnormalities and reduced transcription of a functionally rearranged lambda L-chain gene result in the absence of L-chains.  26:177-185. 2000
  • Cardiolipin enhances protein C pathway anticoagulant activity.  26:115-123. 2000
  • Genomic structure of the human p47-phox (ncf1) gene.  26:37-46. 2000
  • The effect of transferrin polymorphisms on iron metabolism.  25:374-379. 1999
  • Analysis of Tlr4-mediated LPS signal transduction in macrophages by mutational modification of the receptor.  25:328-338. 1999
  • Homology models of the C domains of blood coagulation factors V and VIII: A proposed membrane binding mode for FV and FVIII C2 domains.  24:448-461. 1998
  • alpha2- macroglobulin and C1-inactivator are plasma inhibitors of human glandular kallikrein.  24:412-419. 1998
  • Genetic and physical mapping of the Lps locus: Identification of the Toll-4 receptor as a candidate gene in the critical region.  24:340-355. 1998
  • TNF, apoptosis and autoimmunity: a common thread?.  24:216-230. 1998
  • The human nramp2 gene: Characterization of the gene structure, alternative splicing, promoter region and polymorphisms.  24:199-215. 1998
  • Involvement of amino acid residues 423-429 of human protein S in binding to C4b-binding protein.  24:101-113. 1998
  • Crystal structure of NMC-4 fab anti-von Willebrand factor A1 domain.  23:123-134. 1997
  • Cloning of the murine platelet glycoprotein Ib alpha gene highlighting species-specific platelet adhesion.  23:292-301. 1997
  • Selective interaction of a conformationally-constrained Arg-Gly-Asp (RGD) motif with the integrin receptor alpha v beta 3 expressed on human tumor cells.  23:230-241. 1997
  • Multicentric epithelioid angiosarcoma of the bone. Pitfalls in clinical and morphological diagnosis.  22:205-213. 1996
  • Mutation analysis in hereditary hemochromatosis.  22:187-194. 1996
  • A strategy for cloning the hereditary hemochromatosis gene.  21:207-216. 1995
  • Platelet microparticles bind, activate and aggregate neutrophils in vitro - Commentary.  21:A231-A231. 1995
  • The clinical course of treated and untreated Gaucher disease. A study of 45 patients..  21:86-108. 1995
scroll to property group menus

Identity

International Standard Serial Number (ISSN)

  • 1079-9796

Electronic International Standard Serial Number (EISSN)

  • 1096-0961

©2021 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support